Relationships among body mass index, longitudinal body composition alterations, and survival in patients with locally advanced pancreatic cancer receiving chemoradiation: A pilot study

Journal of Pain and Symptom Management

Volumn 44, Issue 2, 2012, Pages 181-191

  Dalal, Shalini ^a   Hui, David ^a   Bidaut, Luc ^a   Lem, Kristen ^a   Del Fabbro, Egidio ^a   Crane, Christopher ^a   Reyes Gibby, Cielito C ^a   Bedi, Deepak ^a   Bruera, Eduardo ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

body composition alterations; cancer; Cancer cachexia; obesity and pancreatic cancer; pancreatic cancer

Indexed keywords

BEVACIZUMAB; CAPECITABINE;

ADULT; ADVANCED CANCER; AGE; AGED; ARTICLE; BODY COMPOSITION; BODY MASS; CANCER PATIENT; CANCER SURVIVAL; CHEMORADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FOLLOW UP; HUMAN; INOPERABLE CANCER; INTRAABDOMINAL FAT; MALE; MORTALITY; MUSCLE ATROPHY; OBESITY; PANCREAS CANCER; PILOT STUDY; SKELETAL MUSCLE; SUBCUTANEOUS FAT; SURVIVAL TIME; TREATMENT OUTCOME; WEIGHT REDUCTION;

ADIPOSE TISSUE; ADULT; AGED; AGED, 80 AND OVER; ANTHROPOMETRY; BODY COMPOSITION; BODY MASS INDEX; CACHEXIA; CHEMORADIOTHERAPY; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MUSCLE, SKELETAL; PANCREATIC NEOPLASMS; PILOT PROJECTS; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; WEIGHT LOSS;

EID: 84864580287     PISSN: 08853924     EISSN: 18736513     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2011.09.010     Document Type: Article

References (52)

1. W.J. Evans, J.E. Morley, and J. Argiles Cachexia: a new definition Clin Nutr 27 2008 793 799
2. D. Blum, A. Omlin, and K. Fearon Evolving classification systems for cancer cachexia: ready for clinical practice? Support Care Cancer 18 2010 273 279
3. W.D. Dewys, C. Begg, and P.T. Lavin Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group Am J Med 69 1980 491 497
4. J.H. Shaw, and R.R. Wolfe Fatty acid and glycerol kinetics in septic patients and in patients with gastrointestinal cancer. The response to glucose infusion and parenteral feeding Ann Surg 205 1987 368 376
5. H.J. Andreyev, A.R. Norman, J. Oates, and D. Cunningham Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? Eur J Cancer 34 1998 503 509
6. J. Bachmann, M. Heiligensetzer, and H. Krakowski-Roosen Cachexia worsens prognosis in patients with resectable pancreatic cancer J Gastrointest Surg 12 2008 1193 1201
7. J. Ockenga, M. Pirlich, S. Gastell, and H. Lochs Tumour anorexia-tumour cachexia in case of gastrointestinal tumours: standards and visions [in German] Z Gastroenterol 40 2002 929 936
8. C. Deans, and S.J. Wigmore Systemic inflammation, cachexia and prognosis in patients with cancer Curr Opin Clin Nutr Metab Care 8 2005 265 269
9. D. Li, J.S. Morris, and J. Liu Body mass index and risk, age of onset, and survival in patients with pancreatic cancer JAMA 301 2009 2553 2562
10. A.A. Arslan, K.J. Helzlsouer, and C. Kooperberg Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan) Arch Intern Med 170 2010 791 802
11. E.E. Calle, C. Rodriguez, K. Walker-Thurmond, and M.J. Thun Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults N Engl J Med 348 2003 1625 1638
12. L. Fontana, J.C. Eagon, M.E. Trujillo, P.E. Scherer, and S. Klein Visceral fat adipokine secretion is associated with systemic inflammation in obese humans Diabetes 56 2007 1010 1013
13. L.A. Schaap, S.M. Pluijm, D.J. Deeg, and M. Visser Inflammatory markers and loss of muscle mass (sarcopenia) and strength Am J Med 119 2006 526.e9 526.e17
14. D.B. Panagiotakos, C. Pitsavos, M. Yannakoulia, C. Chrysohoou, and C. Stefanadis The implication of obesity and central fat on markers of chronic inflammation: the ATTICA study Atherosclerosis 183 2005 308 315
15. N. Makhsida, J. Shah, G. Yan, H. Fisch, and R. Shabsigh Hypogonadism and metabolic syndrome: implications for testosterone therapy J Urol 174 2005 827 834
16. B.L. Wajchenberg Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome Endocr Rev 21 2000 697 738
17. T. Pischon, H. Boeing, and K. Hoffmann General and abdominal adiposity and risk of death in Europe N Engl J Med 359 2008 2105 2120
18. P.J. Anderson, J.A. Critchley, and J.C. Chan Factor analysis of the metabolic syndrome: obesity vs insulin resistance as the central abnormality Int J Obes Relat Metab Disord 25 2001 1782 1788
19. T.S. Han, K. Williams, and N. Sattar Analysis of obesity and hyperinsulinemia in the development of metabolic syndrome: San Antonio Heart Study Obes Res 10 2002 923 931
20. B.H. Tan, L.A. Birdsell, L. Martin, V.E. Baracos, and K.C. Fearon Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer Clin Cancer Res 15 2009 6973 6979
21. C.J. Balentine, J. Enriquez, and W. Fisher Intra-abdominal fat predicts survival in pancreatic cancer J Gastrointest Surg 14 2010 1832 1837
22. V.E. Baracos, T. Reiman, M. Mourtzakis, I. Gioulbasanis, and S. Antoun Body composition in patients with non-small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis Am J Clin Nutr 91 2010 1133S 1137S
23. C.M. Prado, J.R. Lieffers, and L.J. McCargar Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study Lancet Oncol 9 2008 629 635
24. E.S. Freedland Role of a critical visceral adipose tissue threshold (CVATT) in metabolic syndrome: implications for controlling dietary carbohydrates: a review Nutr Metab (Lond) 1 2004 12
25. S.R. Smith, and J.J. Zachwieja Visceral adipose tissue: a critical review of intervention strategies Int J Obes Relat Metab Disord 23 1999 329 335
26. T. Agustsson, M. Ryden, and J. Hoffstedt Mechanism of increased lipolysis in cancer cachexia Cancer Res 67 2007 5531 5537
27. H. Ogiwara, S. Takahashi, and Y. Kato Diminished visceral adipose tissue in cancer cachexia J Surg Oncol 57 1994 129 133
28. R.A. Murphy, M.S. Wilke, and M. Perrine Loss of adipose tissue and plasma phospholipids: relationship to survival in advanced cancer patients Clin Nutr 29 2010 482 487
29. C.H. Crane, L.M. Ellis, and J.L. Abbruzzese Phase I trial evaluating the safety of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer J Clin Oncol 24 2006 1145 1151
30. C.C. Reyes-Gibby, W. Chan, and J.L. Abbruzzese Patterns of self-reported symptoms in pancreatic cancer patients receiving chemoradiation J Pain Symptom Manage 34 2007 244 252
31. World Health Organization Obesity: Preventing and managing the global epidemic. Report of a WHO Consultation 2000 World Health Organization Geneva, Switzerland
32. C.M.M. Prado, V.E. Baracos, and L.J. McCargar Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity Clin Cancer Res 13 2007 3264 3268
33. M. Mourtzakis, C.M. Prado, and J.R. Lieffers A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care Appl Physiol Nutr Metab 33 2008 997 1006
34. C.S. Cleeland, T.R. Mendoza, and X.S. Wang Assessing symptom distress in cancer patients: the M. D. Anderson Symptom Inventory Cancer 89 2000 1634 1646
35. M.O. Ivanova, T.I. Ionova, and S.A. Kalyadina Cancer-related symptom assessment in Russia: validation and utility of the Russian M. D. Anderson Symptom Inventory J Pain Symptom Manage 30 2005 443 453
36. K. Fearon, F. Strasser, and S.D. Anker Definition and classification of cancer cachexia: an international consensus Lancet Oncol 12 2011 489 495
37. K.M. Flegal, M.D. Carroll, C.L. Ogden, and L.R. Curtin Prevalence and trends in obesity among US adults, 1999-2008 JAMA 303 2010 235 241
38. S.C. Larsson, N. Orsini, and A. Wolk Body mass index and pancreatic cancer risk: a meta-analysis of prospective studies Int J Cancer 120 2007 1993 1998
39. E.E. Calle, and R. Kaaks Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms Nat Rev Cancer 4 2004 579 591
40. T. You, A.S. Ryan, and B.J. Nicklas The metabolic syndrome in obese postmenopausal women: relationship to body composition, visceral fat, and inflammation J Clin Endocrinol Metab 89 2004 5517 5522
41. S. Yamashita, T. Nakamura, and I. Shimomura Insulin resistance and body fat distribution Diabetes Care 19 1996 287 291
42. C. Bing, S. Russell, and E. Becket Adipose atrophy in cancer cachexia: morphologic and molecular analysis of adipose tissue in tumour-bearing mice Br J Cancer 95 2006 1028 1037
43. D.T. Villareal, M. Banks, D.R. Sinacore, C. Siener, and S. Klein Effect of weight loss and exercise on frailty in obese older adults Arch Intern Med 166 2006 860 866
44. G. Mazzali, V. Di Francesco, and E. Zoico Interrelations between fat distribution, muscle lipid content, adipocytokines, and insulin resistance: effect of moderate weight loss in older women Am J Clin Nutr 84 2006 1193 1199
45. T.D. Filippatos, D.N. Kiortsis, E.N. Liberopoulos, D.P. Mikhailidis, and M.S. Elisaf A review of the metabolic effects of sibutramine Curr Med Res Opin 21 2005 457 468
46. R.D. Brook, R.L. Bard, and L. Glazewski Effect of short-term weight loss on the metabolic syndrome and conduit vascular endothelial function in overweight adults Am J Cardiol 93 2004 1012 1016
47. B.H. Goodpaster, D.E. Kelley, R.R. Wing, A. Meier, and F.L. Thaete Effects of weight loss on regional fat distribution and insulin sensitivity in obesity Diabetes 48 1999 839 847
48. M.J. Tisdale Zinc-alpha2-glycoprotein in cachexia and obesity Curr Opin Support Palliat Care 3 2009 288 293
49. K.C. Fearon Cancer cachexia and fat-muscle physiology N Engl J Med 365 2011 565 567
50. S.K. Das, S. Eder, and S. Schauer Adipose triglyceride lipase contributes to cancer-associated cachexia Science 333 2011 233 238
51. T. Poterucha, B. Burnette, and A. Jatoi A decline in weight and attrition of muscle in colorectal cancer patients receiving chemotherapy with bevacizumab Med Oncol 29 2012 1005 1009
52. S. Antoun, L. Birdsell, and M.B. Sawyer Association of skeletal muscle wasting with treatment with sorafenib in patients with advanced renal cell carcinoma: results from a placebo-controlled study J Clin Oncol 28 2010 1054 1060